Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer displays an updated ClinicalTrials.gov site revision, from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T12:50:12.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence.” The clinical trial details and record history are unchanged.
    Difference
    0.6%
    Check dated 2026-10-26T14:28:23.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:40:43.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:48:04.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.7.0 was added to the study record history, and the previous v3.6.6 entry was removed.
    Difference
    0.1%
    Check dated 2026-09-21T22:09:18.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision entry updated to v3.6.6, replacing v3.6.5 in the page history. This reflects a minor system update to the history records and does not change study data or content.
    Difference
    0.1%
    Check dated 2026-08-31T17:19:32.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.